A Comparative Study to Valuating the Efficacy and Safety of QL1206 and Prolia®
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Prolia®
Related studies linked through entity extraction aliases.
A Study on Efficacy, Safety and Immunogenicity of 9MW0311 in Postmenopausal Women With Osteoporosis
- Status
- RECRUITING
- Phase
- PHASE3
A Study for the Evaluation of Efficacy and Safety of Prolia® in Participants With Glucocorticoid-induced Osteoporosis in Mainland China
- Status
- RECRUITING
- Phase
- PHASE4
Study to Compare the Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of MAB-22 Versus Prolia®
- Status
- WITHDRAWN
- Phase
- PHASE3
A Study to Evaluate the Efficacy and Safety of HLX14 vs. Denosumab Prolia® in Postmenopausal Women With Osteoporosis at High Risk of Fracture
- Status
- COMPLETED
- Phase
- PHASE3
Comparison of Efficacy, Pharmacodynamics, Safety, and Immunogenicity Between Bmab 1000 and Prolia® in Postmenopausal Women With Osteoporosis
- Status
- COMPLETED
- Phase
- PHASE3
Comparison of Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Bmab 1000 and Prolia® in Normal Healthy Volunteers: DENARIUS: DENosumab Pharmacokinetic equivAlence tRIal in Healthy volUnteerS
- Status
- COMPLETED
- Phase
- PHASE1
Comparative Efficacy and Safety Study of RGB-14-P and Prolia® in Women With Postmenopausal Osteoporosis
- Status
- COMPLETED
- Phase
- PHASE3
Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of MW031 and Prolia® in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Efficacy and Safety Comparative Study Between CMAB807 Injection and Prolia® .
- Status
- COMPLETED
- Phase
- PHASE3
Comparing of the Pharmacokinetic, Safety and Pharmacodynamic of QL1206 and Prolia® in Healthy Adults
- Status
- UNKNOWN
- Phase
- PHASE1
Phase 1 Study to Compare CMAB807 Injection to Prolia® in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1